TAR-200 Intravesical Drug-Releasing System (Johnson & Johnson) for Non-Muscle-Invasive Bladder Cancer

An intravesical gemcitabine-releasing device under investigation for the treatment of patients with bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle invasive bladder cancer (HR-NMIBC).